India’s Patent Office revokes Sutent cancer drug patent

14-02-2013

India’s Patent Office has revoked pharmaceutical company Sugen and licensee Pfizer’s patent for the cancer drug Sutent, agreeing with Indian drugs maker Cipla that it lacks inventive step.


India, Patent Office, Pfizer, Sugen, Sutent, Cipla

More on this story

IPAB sets aside Sutent patent rejection
07-06-2013

WIPR